Patient Behavior in Region H: How Does Illness Affect How You Act and Master Your Life?

May 15, 2023 updated by: Anette Lykke Hindhede, Rigshospitalet, Denmark
This study investigates how the behavior within different patient groups are affected differently by illness and disease. The investigators ask how participants experience and approach their own health in order to gain insight on the implications of illness and disease on the individual's everyday life and how participants act and think regarding their own health and wellbeing across different patient groups. The investigators' hypothesis is that illness and disease is experienced as a great disturbance and an actor of change in a person's everyday life. Each person has their own individual experience and reaction to this disturbance. Still, there is less evidence for how disparate resources and socioeconomic statuses shape how patients react to this great change in their lives. Here the investigators expect to find demographic patterns across patient groups. The study carries a quantitative and qualitative approach with a broad target population which includes both patients with acute or chronic, serious, or less serious, somatic as well as psychiatric illnesses. The study is placed within the academic traditions of sociological health and disease mapping.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Population consists of patients connected to a hospital clinic in Region H. We aim for a representative sample of patients in general and specific patient groups connected to a hospital within Region Hovedstaden

Description

Inclusion Criteria:

  • The patient is assigned to Region H
  • The patient is over the age of 18
  • The patient is able to answer the questions

Exclusion Criteria:

  • - The patient refuses to give informed consent
  • The patient doesn't speak danish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients in Region H
The health care system in Region H consists of 10 hospitals, including Region H's Psychiatry which consists of 11 centers. The hospitals annually have around 3 million visits from outpatients
Participants are expected to answer a short survey based on their overall experiences with their own health. No participants will therefore be followed for more than the duration of time it takes a subject to answer the questionnaire (approx 15 minutes). Randomly selected volunteers of around 30 respondents will afterwards be invited to participate in a qualitative interview with the intend to elaborate their questionnaire responds.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Online questionnaire/survey
Time Frame: six months
Investigators have developed a medical education survey in Danish for the participants to answer individually or with investigators' help. Participants are expected to give their informed consent before beginning the survey. In order to verify the quality of the survey investigators conducted preliminary cognitive interviewing on 10 participants broadly represented by gender, age, diagnosis' etc. Cognitive interviewing is an evidence based qualitative research method designed to investigate if a questionnaire fulfills its intended purpose and thereby ensures to improve education surveys . With help from an investigator respondents are expected to "think out loud" while answering the questionnaire. In the questionnaire, investigators ask participants about their socioeconomic background as well as questions about exercise, diets, alcohol, mental well being often in the context of their actions before and after receiving a diagnosis or becoming ill.
six months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Multiple correspondence analysis
Time Frame: through study completion, an average of 6 months

Investigators plan to interpret investigators' data through a Multiple Correspondence Analysis (MCA) . MCA is a statistical approach utilized among others by sociologist Pierre Bourdieu in order to construct social fields and spaces with his empirical data . Through MCA investigators can analyze the pattern of relationships of several categorical dependent variables such as diagnosis, income, age, diet, geography etc.

As such, it can also be seen as a generalization of principal component analysis when the variables to be analyzed are categorical instead of quantitative

through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Anticipated)

September 1, 2023

Study Completion (Anticipated)

March 1, 2024

Study Registration Dates

First Submitted

May 4, 2023

First Submitted That Met QC Criteria

May 15, 2023

First Posted (Actual)

May 17, 2023

Study Record Updates

Last Update Posted (Actual)

May 17, 2023

Last Update Submitted That Met QC Criteria

May 15, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • P-2022-764

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Comparison, Social

Clinical Trials on Online questionnaire/survey

3
Subscribe